No More Pricks – Quick Dissolvable Tablet is Set to Disrupt the Vaccine Industry
August 10 2017 - 8:00AM
Business Wire
White Coat Productions documentary in development explores the
global impact of vaccine delivery advancements
The quest to improve vaccination efforts in developing nations
may yield huge side benefits to the industrialized world; an end to
needle injections.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170810005176/en/
Catalent scientists have developed a quick dissolving tablet
they hope can provide an option to replace some needle injections
for vaccination. Imagine back-to-school doctor visits without your
children kicking and screaming, afraid of their doctor’s
syringe!
There are clear additional benefits in the efforts to vaccinate
impoverished populations in remote corners of the world. Currently,
many vaccines require a “cold-chain” so their temperature is
maintained constantly by refrigeration throughout delivery. The
need for a cold chain is a serious obstacle in trying to reach
regions where refrigeration isn’t available, and where temperatures
are often higher.
Recently published in the journal Vaccine, Johns Hopkins
Bloomberg School of Health Professor Bruce Lee, M.D. reports of a
significant economic advantage in developing temperature stable
vaccines.
As part of an effort to eliminate the cold chain, scientists
using temperature stable Zydis® technology are customizing their
formulations and say they are on the cutting edge of manufacturing
vaccine doses that dissolve on the tongue within a few seconds,
eliminating the need for needle injections, which can also pose
challenges for maintaining sterility in some environments.
Research and development is currently being conducted at
Catalent’s laboratories in Swindon, U.K., where chemists have
already been successful in developing commercial platforms for
treatments such as immunotherapy for allergy relief.
A documentary on the need for improved vaccination deployment is
in development at White Coat Productions, a video content creation
firm based in the DC/Baltimore metro area.
Video news release available at the following link:
https://vimeo.com/227783144SME’s available on appointment basis
Zydis is a registered trademark of R.P. Scherer Technologies,
Inc., a subsidiary of Catalent Pharma Solutions, Inc. Used with
permission.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170810005176/en/
White Coat ProductionsDavid Wasser, 202-256-4709orPat Brogan,
703-462-0530WhiteCoatProductions@gmail.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From Sep 2023 to Sep 2024